Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming to prepare for future infectious diseases. A research team has newly ...
Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a ...
Metformin use soon after COVID-19 infection is associated with a 53% reduction in long COVID or death risk, reinforcing ...
S-880008 is a lipidated macrocyclic peptide that broadly inhibits SARS-CoV-2 variants. By locking spike proteins in a fusion-incompetent state through interactions with conserved sites, it blocks ...
A study co-led by a University of California, Riverside, biomedical scientist has identified new targets for coronavirus ...
Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19. New research ...
A study shows the plant alkaloid fangchinoline suppresses transmissible gastroenteritis virus in swine cells by targeting porcine aminopeptidase N.
Health and Me on MSN
Common diabetes drug metformin may slash long COVID risk by more than 50%
A recent study published in Journal of Medical Virology, based on health records of 21 million people, found that popular ...
A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...
UC San Diego study identifies new potential treatment targets for COVID-19 and other diseases caused by coronaviruses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results